All good from here.
Guidance i consider as v v solid
THAT TOO FROM A V V CONSERVATIVE MANAGEMENT.
Mayne Pharma controls 53.5% of HPPI and has consolidated 100% of HPPI, in accordance with accounting standards, into the financial statements following this Directors’ Report. The Group recorded revenue of $525.2m, down 1% on pcp and gross profit was $289.9m up 13% on pcp. Gross profit margin as a percentage of revenue was 55.2% (2018: 48.4%) which reflects the greater contribution from Specialty Brands which has a higher margin profile, favourable product sales mix in generics and normalised levels of stock obsolescence and DORYX returns.
Amazing Gross margins and going up too. from 48.4% to 55.2
higher gross margins thatn CSL for sure.
Bring on the next financial yr end numbers now as slate is clear. Cant wait.
70 cents per share is NTA or net equity.
so cheap. shold sell at 5-7 times net asts
MYX Price at posting:
47.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)